Skip to main content

Nkarta, Inc.

NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787400

No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Nkarta, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of NKTX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders1121119+8
Shares66.2M4.06M66.8M+4.59M (+7.4%)
Value$391.5M$24.0M$301.7M−$65.8M (−17.9%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (21)

Institutions that held Nkarta, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Sold out (13)

Institutions that held Nkarta, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of NKTX in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Federated Hermes, Inc.135,749$802.3K
Schonfeld Strategic Advisors LLC68,517$404.9K
Jump Financial, LLC67,205$397.2K
Simplicity Wealth,LLC37,486$221.5K
Verition Fund Management LLC35,298$208.6K
Alpine Global Management, LLC23,161$136.9K
Y-Intercept (Hong Kong) Ltd20,872$123.4K
Susquehanna International Group, LLP18,500$109.3K
Bayesian Capital Management, LP14,979$88.5K
Two Sigma Advisers, LP14,600$86.3K
Level Four Advisory Services, LLC12,000$70.9K
Russell Investments Group, Ltd.2,423$14.3K
Lindbrook Capital, LLC73$431

Not filed for Q3 2024 yet (1)

Institutions that held Nkarta, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NKTX in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.4,059,362$24.0M